Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,487 | 7,416 | 15,722 | 6,638 | 5,496 |
| Marketable Securities | 3 | N/A | N/A | N/A | N/A |
| Receivables | 1,420 | 1,014 | 1,191 | 818 | 1,115 |
| Inventories | 266 | 254 | 258 | 237 | 179 |
| TOTAL | $32,405 | $9,940 | $18,646 | $9,247 | $7,950 |
| Non-Current Assets | |||||
| PPE Net | 2,858 | 2,759 | 2,983 | 2,959 | 2,998 |
| Intangibles | 38,848 | 42,104 | 43,472 | 44,840 | 46,208 |
| Other Non-Current Assets | 790 | 853 | 884 | 904 | 574 |
| TOTAL | $42,496 | $45,715 | $47,339 | $48,703 | $49,780 |
| Total Assets | $74,901 | $55,655 | $65,985 | $57,950 | $57,730 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,803 | 5,551 | 4,742 | 5,443 | 6,723 |
| TOTAL | $7,069 | $5,789 | $5,070 | $5,621 | $6,958 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 208 | 178 | 270 | 178 | 235 |
| Other Non-Current Liabilities | 2,647 | 1,762 | 1,884 | 1,637 | 6,634 |
| TOTAL | $5,109 | $10,911 | $14,332 | $6,965 | $8,510 |
| Total Liabilities | $12,178 | $16,700 | $19,401 | $12,586 | $15,467 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,155 | 83,122 | 73,690 | 72,149 | 69,599 |
| Common Shares | 234,850 | 201,298 | 199,944 | 211,943 | 203,456 |
| Retained earnings | -182,190 | -171,607 | -163,387 | -153,878 | -145,779 |
| Other shareholders' equity | 26,563 | 27,703 | 28,468 | 25,704 | 27,490 |
| TOTAL | $62,723 | $38,955 | $46,584 | $45,364 | $42,262 |
| Total Liabilities And Equity | $74,901 | $55,655 | $65,985 | $57,950 | $57,730 |